Peer-reviewedCC BY 4.0BMC Medicine
Colchicine use and cardiovascular event risk in Chinese adults starting urate-lowering therapy: a cohort study
Related
- Continuous renal replacement therapy successfully treating a young male with acute kidney injury and multiple organ dysfunction by severe colchicine poisoning: A case report
- Comparing Cardiovascular Outcomes in New Users of Oral Semaglutide Versus Other Noninsulin Glucose-Lowering Therapies Among Adults with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
- Remnant cholesterol, C-reactive protein, cholesterol-lowering medication, and cardiovascular outcome: novel findings from UK Biobank.
- Five Trials, Five Different Questions: Design Heterogeneity Among Lipoprotein(a)-Lowering Cardiovascular Outcomes Trials After Lp(a)HORIZON
- Comparative effectiveness of lipid-lowering therapies for primary cardiovascular prevention: a network meta-analysis of randomised controlled trials
BibTeX
@article{yang2026colchicine,
title = {{Colchicine use and cardiovascular event risk in Chinese adults starting urate-lowering therapy: a cohort study}},
author = {Ruotong Yang and Huan Yu and Kun Wang and Junhui Wu and Mengying Wang and Xueying Qin and Tao Wu and Yiqun Wu and Yonghua Hu},
journal = {BMC Medicine},
year = {2026},
month = nov,
doi = {10.1186/s12916-026-05384-9},
url = {https://link.springer.com/article/10.1186/s12916-026-05384-9},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Colchicine use and cardiovascular event risk in Chinese adults starting urate-lowering therapy: a cohort study
AU - Ruotong Yang
AU - Huan Yu
AU - Kun Wang
AU - Junhui Wu
AU - Mengying Wang
AU - Xueying Qin
AU - Tao Wu
AU - Yiqun Wu
AU - Yonghua Hu
PY - 2026
DA - 2026/11/03
JO - BMC Medicine
DO - 10.1186/s12916-026-05384-9
UR - https://link.springer.com/article/10.1186/s12916-026-05384-9
SN - 1741-7015
ER -